R-2487
- Generic Name
- R-2487
R-2487 in Patients With Sjogren's Syndrome (SS)
Phase 1
Not yet recruiting
- Conditions
- SjögrenSjogren's SyndromeSjögren Syndrome, Unspecified
- Interventions
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Rise Therapeutics LLC
- Target Recruit Count
- 36
- Registration Number
- NCT06297213
R-2487 in Patients with Rheumatoid Arthritis
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Rise Therapeutics LLC
- Target Recruit Count
- 36
- Registration Number
- NCT05961592
- Locations
- 🇺🇸
St.Jude Clinical Research, Doral, Florida, United States
🇺🇸AP Medical Research, Miami, Florida, United States
🇺🇸Altoona Center for Research, Duncansville, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath